- About Us
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Child Advocacy
- Emergency Medicine
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Infectious Diseases
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research Administration
- Cores and Research Support
- Information Technology
- Communications Team
- Anti-Racism Statement
- Our Core Principles
- Our Goals
- Community and Culture
- Nondiscrimination Statement
- Continuing Medical Education
- Medical Student Education and Training
- CHP VUE: Vital URiM Experience
- Maintenance of Certification Portfolio Program
- Summer Research Internship
- Faculty Affairs
- Faculty Mentoring
- Leadership Development
- Professional Development and Career Advancement
- Educator Development
- For New Faculty
- Faculty Promotion
- Grant Programs
- Wellness Resources
- Faculty Well-being Task Force
- Thank Yinz
Dana Y. Fuhrman, DO, MS
- Assistant Professor of Critical Care Medicine and Pediatrics
- Associate Program Director, Pediatric Critical Care Medicine Fellowship
Administrative Assistant: Vickie Johnson
As a pediatric nephrologist and intensivist, Dr. Fuhrman’s overall research interests are in the areas of acute kidney injury (AKI) and continuous renal replacement therapy. Currently, her research focus is in the prevention and early detection of AKI in children. She is interested in studying renal reserve as defined by the difference in a baseline and a protein stimulated glomerular filtration rate. She plans to determine if children with lower renal reserve values are at a greater risk for AKI after cardiac surgery. Also, she is interested in investigating if the cell cycle arrest biomarkers, tissue inhibitor of metalloproteinases-2 and insulin-like growth factor binding protein 7, could be used to predict the risk and earlier diagnosis of AKI in this patient population.
Professional and Scientific Society Memberships
- American Society of Nephrology, 2009-Present
- American Society of Pediatric Nephrology, 2010-Present
- Society of Critical Care Medicine, 2013-Present
- National Kidney Foundation, 2018-Present
Education & Training
- BS, Biology/Psychology, Allegheny College, 2000
- DO, Philadelphia College of Osteopathic Medicine, 2005
- Internship, Christiana Care Health System, 2005-2006
- Residency in Pediatrics, University of Rochester, 2006-2009
- Chief Resident, University of Rochester, 2009-2010
- Fellowship in Pediatric Nephrology, University of Rochester, 2010-2013
- MS, Clinical Investigation, University of Rochester, 2013
- Fellowship in Pediatric Critical Care Medicine, UPMC Children's Hospital of Pittsburgh, 2013-2015
Joyce EL, Kane-Gill SL, Fuhrman DY, Kellum JA. Drug-associated acute kidney injury: who’s at risk? Pediar Nephrol. 2017 Jan 32(1):59-69. PMID: 27338726.
Fuhrman DY, Kellum JA. Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 2017 Feb 30(1):60-65. PMID: 2780742.
Rodenbach KE, Fuhrman DY, Maier PS, Schwartz GJ. Renal response to a protein load in healthy young adults as determined by iohexol infusion clearance, cimetidine-inhibited creatinine clearance, and cystatin C estimated glomerular filtration rate. J Ren Nutr. 2017 Jul 27(4):275-281. PMID: 28389059.
Fuhrman DY, Schneider MF, Dell KM, Blydt-Hansen TD, Mak R, Saland JM, Furth SL, Warady BA, Moxey-Mims MM, Schwartz GJ. Albuminuria, proteinuria, and renal disease progression in children with CKD. Clin J Am Soc Nephrol. 2017 Jun 12(6):912-920. PMID: 28546440.
Fuhrman DY, Crowley K, Vetterly C, Hushitsuki K, Koval A, Carcillo. Medication use as a contributor to fluid overload in the PICU: a prospective observational study. J Pediatr Intensive Care. 2018 Jun 7(2):69-74. PMID: 31073473.
Fuhrman DY, Kane-Gill S, Goldstein SL, Priyanka P, Kellum JA. Acute kidney injury epidemiology, risk factors, and outcomes in critically ill patients 16-25 years of age treated in an adult intensive care unit. Ann Intensive Care. 2018 Feb 8(1):26. PMID: 29445884.
Joyce, EL, DeAlmeida DR, Fuhrman DY, Priyanka P, Kellum JA. eResearch in acute kidney injury: a primer for electronic health record research. Nephrol Dial Transplant. 2019 Mar 34(3):401-417. PMID: 29617846.
Fuhrman DY, Nguyen LG, Sanchez-de-Toledo J, Priyanka P, Kellum JA. Postoperative acute kidney injury in young adults with congenital heart disease. Ann Thoracic Surg. 2019 May 107(5):1416-1420. PMID: 30763561.
Joyce EL, Kane-Gill SL, Priyanka P, Fuhrman DY, Kellum JA. Piperacillin/Tazobactam and antibiotic-associated acute kidney injury in critically ill children. J Am Soc Nephrol. 2019 Sep [Epub ahead of print]. PMID: 31501354.
Fuhrman DY, Kellum JA, Joyce EL, Miyashita Y, Mazariegos GV, Ganoza A, Squires JE. The use of urinary biomarkers to predict acute kidney injury in children after liver transplant. Pediatr Transplant. 2019 Oct [Epub ahead of print]. PMID: 31652022.
Fuhrman, DY, Nguyen L, Hindes M, Kellum JA. Baseline tubular biomarkers in young adults with congenital heart disease as compared to healthy young adults: detecting subclinical kidney injury. Congenit Heart Dis. 2019 Dec [Epub ahead of print]. PMID: 31793232.
Academic and Research Interests
- Acute Kidney Injury
- The Acute Kidney Injury to Chronic Kidney Injury Transition
- Continuous Renal Replacement Therapy
- Renal Functional Reserve
- Nephrotoxin Associated Acute Kidney Injury
NIH K23DK116973, Renal Fitness in Young Adults with Congenital Heart Disease (PI), 2019-2024, $921,493.
Biomerieux Global Medical Affairs Team, Renal Fitness in Patients with Congenital Heart Disease (PI), 2020-2022, $36,632.